Affimed NV (NASDAQ:AFMD)
| 6.07 Delayed Data As of 3:59pm ET |  +0.09 / +1.51%Today’s Change | 3.09 Today|||52-Week Range 11.74 | +4.30% Year-to-Date |
Latest AFMD News | Press Releases
| 2 Biotech Stocks Set to Go Supernova Soon Oct 18 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 5.98 |
| Today’s open | 6.01 |
| Day’s range | 5.98 - 6.17 |
| Volume | 28,233 |
| Average volume (3 months) | 1,048,226 |
| Market cap | $708.2M |
Data as of 3:59pm ET, 10/20/2021
Growth & Valuation
| Earnings growth (last year) | -0.18% |
| Earnings growth (this year) | +12.50% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +35.03% |
| P/E ratio | NM |
| Price/Sales | 15.03 |
| Price/Book | 6.60 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PETQPetIQ Inc | +0.28 | +1.14% |
| LXRXLexicon Pharmaceutic... | +0.07 | +1.39% |
| EGRXEagle Pharmaceutical... | -0.46 | -0.87% |
| ORMPOramed Pharmaceutica... | -0.65 | -2.85% |
Data as of 4:00pm ET, 10/20/2021
Financials
| Next reporting date | November 10, 2021 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $32.3M |
| Annual profit (last year) | -$47.2M |
| Net profit margin | -145.86% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
